Home/Filings/4/0001209191-18-013691
4//SEC Filing

Lamberti Frank 4

Accession 0001209191-18-013691

CIK 0001180262other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 9:19 PM ET

Size

15.7 KB

Accession

0001209191-18-013691

Insider Transaction Report

Form 4
Period: 2018-02-22
Lamberti Frank
Chief Commercial Officer
Transactions
  • Award

    Stock Appreciation Rights

    2018-02-22+8,44214,070 total
    Exercise: $30.44From: 2018-03-02Exp: 2025-03-02Common Stock (8,442 underlying)
  • Award

    Stock Appreciation Rights

    2018-02-22+1,5673,134 total
    Exercise: $54.75From: 2018-02-28Exp: 2026-02-28Common Stock (1,567 underlying)
  • Award

    Common Stock

    2018-02-26+1,88211,164 total
  • Award

    Stock Appreciation Rights

    2018-02-22+3,3596,718 total
    Exercise: $62.51From: 2018-05-09Exp: 2026-05-09Common Stock (3,359 underlying)
  • Award

    Stock Appreciation Rights

    2018-02-22+3,5313,531 total
    Exercise: $57.19From: 2018-02-27Exp: 2027-02-27Common Stock (3,531 underlying)
Footnotes (5)
  • [F1]Consists of restricted stock units ("RSU") under the Herbalife Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Ltd. common stock on vesting. This award will vest 20% each on February 26, 2019 and February 26, 2020, and 60% on February 26, 2021.
  • [F2]On March 2, 2015, the reporting person was granted an award of 14,070 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 8,442 which will vest on March 2, 2018.
  • [F3]On February 28,2016, the reporting person was granted an award of 7,837 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 1,567 SARs which will vest on February 28, 2018.
  • [F4]On May 9, 2016, the reporting person was granted an award of 16,795 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 3,359 SARs which will vest on May 9, 2018.
  • [F5]On February 27, 2017, the reporting person was granted an award of 17,655 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2017, 2018 and 2019. The performance criteria for 2017 was met, resulting in 3,531 SARs which will vest on February 27, 2018.

Issuer

HERBALIFE LTD.

CIK 0001180262

Entity typeother

Related Parties

1
  • filerCIK 0001661501

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 9:19 PM ET
Size
15.7 KB